索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 中国知网(CNKI)
  • 引用因子
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Application of Hot Melt Extrusion in Pharmaceutical 3D Printing

Sonal kushwaha

3D printing is one of the rapid prototyping technology, which produces 3D products using layer-by-layer process from digital designs. 3D printing has gained a lot of attention in pharmaceutical industries since FDA approved a 3D-printed SPRITAM® (levitracetam 1000 mg) fast dissolving tablets for the adjunct treatment of myoclonic seizures and primary generalized tonic-clonic seizures. There are various 3D printing methods employed for the drug product manufacturing which are used based on the materials, equipment, and solidification. Hot melt extrusion (HME) is one of the techniques which is used for 3D printing. This review article discusses the application of HME in 3D printing of pharmaceutical products. Uniting Hot melt extrusion (HME) for 3D printing with solid freeform fabrication (SFF) such as Fluid deposition method (FDM) offer great chances for designing a wide variety of drug delivery systems.